Gorson KC, Herrmann DN, Thiagarajan R, Kinsella L, Brannagan TH, Chin RL, Ropper AH. Non-Length Dependent Small Fiber Neuropathy/ Ganglionopathy. J Neurol Neurosurg Psychiatry. 2008;79:163-169.

Neuroimmunology in clinical practice. Kalman B, Brannagan TH, editors. Blackwell. Oxford, 2007, 263 pages.

Gondim FAA, de Sousa EA, Latov N, Sander HW, Chin RL, Brannagan TH. Anti-MAG/SGPG associated neuropathy does not commonly cause distal nerve temporal dispersion. J Neurol Neurosurg Psychiatry. 2007;78:902-904.

Gladstone DE, Golightly MG, Brannagan TH. High Dose Cyclophosphamide Preferentially Targets Naive T (CD45/CD4/RA+) Cells in CIDP and MS Patients. J Neuroimmunology. 2007;190:121-126.

Souayah N, Seltzer, Chin RL, Brannagan TH, Sander HW. Rare Myelin Protein Zero Sequence Variant in Late Onset CMT1B. Journal of the Neurological Sciences. 2007;263:177-179.

Toothaker TB, Brannagan TH. Chronic inflammatory demyelinating polyneuropathies: Current treatment strategies. Current Neurology and Neuroscience Reports. 2007;7:63-70.

Brannagan TH III, Alaedini A, Gladstone DE. High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy. Muscle Nerve. 2006;34:246-250.

de Sousa EA, Hays AP, Chin RL, Sander HW, Brannagan TH III. Characteristics of sensory neuropathy patients diagnosed with abnormal small nerve fibers on skin biopsy. J Neurol Neurosurg Psychiatry. 2006;77:983-985.

Chin RL, Tseng VG, Green PHR, Sander HW, Brannagan TH, Latov N. Multifocal axonal polyneuropathy in celiac disease. Neurology 2006;66:1923-1925.

Goldfarb AR, Latov N, Brannagan TH, Chin RL, de Sousa EA, Sander HW. Correlation of clinical and demyelinating features in patients with neuropathy of otherwise unknown etiology. Neurol Neurophysiol Neurosci. 2006:7:1-9.

de Sousa EA, Brannagan TH. Diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. Current Treatment Options in Neurology. 2006;8:91-103.

Latov N, Gorson KC, Brannagan TH III, Freeman RL, Apostolski S, Berger AR, Bradley WG, Briani C, Bril V, Busis NA, Cros DP, Dalakas MC, Donofrio PD, Dyck PJB, England JD, Fisher MA, Herrmann DN, Menkes, DL, Sahenk Z, Sander HW, Triggs, WJ, Vallat JM. Diagnosis and treatment of chronic immune-mediated neuropathies. J Clin Neuromusc Dis 2006;7:141-157.

Brannagan TH, Hays AP, Chin SS, Sander HW, Chin RL, Green PHR, Latov N. Small fiber neuropathy-neuronopathy in celiac disease ? skin biopsy findings. Arch Neurol. 2005 62:1574-1578.

Gondim FAA, Brannagan TH, Sander HW, Chin RL, Latov N. Peripheral neuropathy in patients with inflammatory bowel disease. Brain. 2005; 128: 867-879.

Renaud S, Hays AP, Brannagan TH 3rd, Sander HW, Edgar M, Weimer LH, Olarte MR, Dalakas M, Xiang Z, Danon M. Latov N. Gene expression profiling in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol. 2005;159:203-214.

Gladstone DE, Pestrud A, Brannagan TH III. High-dose Cyclophosphamide Results in Long-term Disease Remission with Restoration of a Normal Quality of Life in Patients with Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy. J Peripheral Nervous System. 2005;10:11-16.

Brannagan TH, Weimer LH, Latov N. Acquired Neuropathies. In Rowland LP, editor. Merritt?s Neurology. Lippincott Williams & Wilkins, 11th Edition . Lippincott, Williams and Wilkins. Philadelphia, 2005, chapter 106, pp 746-765.

Goldfarb AR, Weimer LH, Brannagan TH. Rituximab treatment of an IgM monoclonal autonomic and sensory neuropathy. Muscle Nerve. 2005;31:510-515.

Goldfarb A, Sander HW, Brannagan TH, Magda P, Latov N. Characterization of neuropathies associated with elevated IgM serum levels. Journal of Neurological Sciences 2005;228:155-160.

Green PHR, Alaedini A, Sander HW, Brannagan TH III, Latov N, Chin RL. Mechanisms underlying celiac disease and its neurologic manifestations. Cellular and Molecular Life Sciences. 2005;62:791-799.

Brannagan TH. Chronic Inflammatory Demyelinating Polyradiculoneuropathy. In Younger DS, editor. Motor Disorders. Lippincott Williams & Wilkins, 2nd Edition, Philadelphia, 2005, chapter 25, pp 323-333.

Brannagan TH, Latov N. Motor Neuropathy and Monoclonal Gammopathy. In Younger DS, editor. Motor Disorders. Lippincott Williams & Wilkins, 2nd Edition, Philadelphia, 2005, chapter 27, pp 343-348.

Chin RL, Latov N, Green PHR, Brannagan III TH, Alaedini A, Sander HW. Neurologic Complications of Celiac Disease. J Clin Neuromuscular Disease. 2004;5:129-137.

Gitig A, Brannagan III T, Scheidt S. Case Report: Acute myocardial infarction associated with intravenous immunoglobulin. Cardiovasc Rev Rep 2004;25:280.

Chin RL, Latov N, Sander HW, Hays AP, Croul SE, Magda P, Brannagan TH. Sensory chronic inflammatory demyelinating polyneuropathy (CIDP) presenting as cryptogenic sensory polyneuropathy. J Peripheral Nervous System. 2004;9:132-137.

Gladstone DE, Brannagan TH, Pestrud AA, Schwartzman RJ, Brodsky I. High-dose cyclophosphamide for severe, refractory Myasthenia Gravis. J Neurol Neurosurg Psychiatry. 2004;75:789-791.

Chin RL, Latov N, Green PHR, Brannagan III TH, Alaedini A, Sander HW. Neurologic Complications of Celiac Disease. J Clin Neuromuscular Disease. 2004;5:129-137.

Brannagan TH, Zhou Y. Human Immunodeficiency Virus Associated Guillain-BarrŽ syndrome. Journal of the Neurological Sciences. 2003;208:39-42.

Brannagan TH. Peripheral Neuropathy Pain: Mechanisms and Treatment. J Clin Neuromuscular Disease. 2003;5:61-71.

Berger AR, Bradley WG, Brannagan TH, Busis NA, Cros DP, Dalakas MC, Danon MJ, Donofrio PD, Engel WK, Feldman EL, Freeman RL, Kinsella LJ, Lacomis D, Latov N, Menkes DL, Sander HW, Thomas FP, Triggs WJ, Windebank AJ, Wolfe GI. Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. J Peripheral Nervous System. 2003;8:282-284.

Magda P, Latov N, Brannagan TH, Weimer LH, Chin RL, Sander HW. Comparison of Electrodiagnostic Abnormalities and Criteria in a Cohort of Patients with CIDP. Arch Neurol. 2003; 60:1755-1759.

Sander HW, Magda P, Chin RL, Wu A, Brannagan TH, Green PHR, Latov N. Cerebellar ataxia and coeliac disease. Lancet. 2003;362:1548.

Chin RL, Sander HW, Brannagan TH, Green PHR, Hays AP, Alaedini A, Latov N. Celiac Neuropathy. Neurology. 2003;60:1581-1585.

Brannagan TH. Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune-mediated neuropathies. Neurology 2002;59(suppl 6):S33-S40.

Brannagan TH, Pradhan A, Heiman-Patterson T, Winkleman AC, Styler MJ, Topolsky DL, Crilley PA, Schwartzman RJ, Brodsky I, Gladstone DE. High-Dose Cyclophosphamide without Stem-Cell Rescue for Refractory Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Neurology 2002;58:1856-1858.

Dabby R, Lange DJ, Trojaborg W, Hays AP, Lovelace RE, Brannagan TH, Rowland LP. Inclusion body myositis mimicking motor neuron disease. Arch Neurol 2001;58:1253-1256.

Brannagan TH, Promisloff RA, McCluskey LF, Mitz KA. Proximal diabetic neuropathy presenting with respiratory weakness. J Neurol Neurosurg Psych 1999;67:539-541.

Brannagan TH, Latov N. Motor Neuropathy and Monoclonal gammopathy. In: Younger DS, editor. Motor Disorders. Lippincott Williams & Wilkins, Philadelphia, 1999, 235-241.

Brannagan TH, McAlarney T, Latov N. Peripheral neuropathy in HIV-1 infection. In Latov N, Wokke JHJ, Kelly JJ eds Immunological and Infectious diseases of the peripheral nerves. Cambridge University Press, 1998; pp 285-307.

Gordon PH, Brannagan TH, Latov N. Neurological manifestations of paraproteinemia and cryoglobulinemia. In P.J. Vinken, G.W. Bruyn, M.J. Aminoff, C. Goetz eds. Handbook of Clinical Neurology, Vol 27(71): Systemic Diseases, Part III. Elsevier Science Ltd. 1998, 431-459.

Brannagan TH. Retrovirus-associated vasculitis of the nervous system. Neurol Clin 1997;15:927-944.

Brannagan TH, Nuovo GJ, Hays AP, Latov N. Human immunodeficiency virus infection of dorsal root ganglion neurons detected by polymerase chain reaction in situ hybridization. Ann Neurol 1997;42:368-372.

Brannagan TH, Hays AP, Lange DJ, Trojaborg W. The Role of quantitative EMG in Inclusion Body Myositis. Journal of Neurology, Neurosurgery and Psychiatry 1997;63:776-779.

Brannagan TH, Nagle KJ, Lange DJ, Rowland LP. Complications of intravenous immune globulin therapy in neurologic disease (Reply from the authors). Neurology [letter] 1997;49:899-900.

Pederson SF, Pullman SL, Latov N, Brannagan TH. Physiological tremor analysis of patients with anti-MAG neuropathy and tremor. Muscle Nerve 1997;20:38-44.

Thomas CE, Mayer SA, Gungor Y, Swarup R, Webster EA, Chang I, Brannagan TH, Fink ME, Rowland LP. Myasthenic Crisis: Clinical Features, Mortality, Complications, and Risk Factors for Prolonged Intubation. Neurology 1997;48:1253-1260.

Brannagan TH, Nagle KJ, Lange DJ, Rowland LP. Complications of intravenous immune globulin therapy in neurologic disease. Neurology 1996;47:674-677.

Briani C, Brannagan TH, Trojaborg W, Latov N. Chronic inflammatory demyelinating polyneuropathy. Neuromuscular Disorders 1996; 6:311-325.

Louis ED, Hanley AE, Brannagan TH, Sherman W, Murphy P, Lange DJ, Trojaborg W, Younger DS, Lovelace RE, Latov N, Rowland LP. Motor neuron disease, lymphoproliferative disease, and bone marrow biopsy. Muscle Nerve 1996;19:1334-1337.

Latov N, Brannagan T, Rowland LP, Sherman WH, Hays AP, Lange DJ, Trojaborg W, Younger DS. SGPG in ALS. Neurology[letter] 1996; 46:1196.